CX 2023 Full programme
Day 3: Innovation Showcase - Thursday, 27th April
Venue: Admiral / Livestream 3
Time: 08:00 - 18:00
Innovation Consensus
Time: 08:00 - 09:20
| Chairing: | Stephen Greenhalgh, London, United Kingdom |
08:00 - 08:05
Lessons learned from a physician inventor: Things we do badly
| Speaker: | Kieran Murphy, Toronto, Canada |
08:05 - 08:10
Audience Participation & Discussion
08:10 - 08:15
Encouraging or stifling role of patents in innovation
| Speaker: | Frank Criado, Baltimore, Maryland, United States |
08:15 - 08:20
Audience Participation & Discussion
08:20 - 08:25
Transforming an enterprise from a focus on aneurysms to PAD
| Speaker: | Matt Thompson, Irvine, United States |
08:25 - 08:30
Audience Participation & Discussion
08:30 - 08:35
Exiting in style: The MedAlliance journey
| Speaker: | Jeffrey Jump, Nyon, Switzerland |
08:35 - 08:40
Audience Participation & Discussion
08:40 - 08:45
How the NHS and "Medicare for all" compare: The UK and US healthcare in one slide
| Speaker: | Firas F Mussa, New York, United States |
08:45 - 08:50
Audience Participation & Discussion
08:50 - 08:55
Returning to the fold: The Veryan Medical journey
| Speaker: | Chas Taylor, Sussex, United Kingdom |
08:55 - 09:00
Audience Participation & Discussion
09:00 - 09:05
Building a company from the ground up: The Xenter journey
| Speaker: | Richard Linder, Sandy, United States |
09:05 - 09:10
Audience Participation & Discussion
09:10 - 09:20
Panel Discussion
Complex AAA Innovation Consensus
Time: 09:20 - 10:10
| Chairing: | Frans Moll, Utrecht, Netherlands |
09:20 - 09:25
Custom-made fenestrated and branched EVAR solutions
| Speaker: | Tilo Koelbel, Hamburg, Germany |
09:25 - 09:30
Audience Participation & Discussion
09:30 - 09:35
Preliminary experience with new self-expandable stent graft in complex aortic repair
| Speaker: | Giacomo Isernia, Perugia, Italy |
09:35 - 09:40
Audience Participation & Discussion
09:40 - 09:45
The power intelligent mapping for complex EVAR
| Speaker: | Tom Carrell, Barrington, United Kingdom |
09:45 - 09:50
Audience Participation & Discussion
09:50 - 09:55
HERCULES RCT design: Comparing the outcomes of ESAR and standard EVAR in wide neck AAAs
| Speaker: | Michel Reijnen, Arnhem, Netherlands |
09:55 - 10:00
Audience Participation & Discussion
10:00 - 10:10
Panel Discussion
Coffee Break
Time: 10:10 - 10:30
AAA Prevention Innovation Consensus
Time: 10:30 - 11:10
| Chairing: | Robert Mitchell, Park City, Utah |
10:30 - 10:35
Early localised drug treatment to inhibit growth of small and mid-size aneurysms
| Speaker: | Andrew Holden, Auckland, New Zealand |
10:35 - 10:40
Audience Participation & Discussion
10:40 - 10:45
Precision medicine for AAA disease
| Speaker: | Randy Moore, Calgary, Canada |
10:45 - 10:50
Audience Participation & Discussion
10:50 - 10:55
Podium First: First-in-human experience with the Vesteck Suture-tight device eliminating migration
| Speaker: | Andrew Holden, Auckland, New Zealand |
10:55 - 11:00
Audience Participation & Discussion
11:00 - 11:10
Panel Discussion
Vascular Access & Renal Innovation Consensus
Time: 11:10 - 12:00
| Chairing: | Stephen Greenhalgh, London, United Kingdom |
11:10 - 11:15
The Holly Device
| Speaker: | Nikhil Shah, Atlanta, United States |
11:15 - 11:20
Audience Participation & Discussion
11:20 - 11:25
Primary and secondary renal cell carcinoma tumor embolization with the GPX embolic device
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:25 - 11:30
Audience Participation & Discussion
11:30 - 11:35
MedTech innovation landscape and opportunities
| Speaker: | Chas Taylor, Sussex, United Kingdom |
11:35 - 11:40
Audience Participation & Discussion
11:40 - 11:45
A wearable device for non-invasive, remote monitoring and classification of access patency and flow characteristics in haemodialysis Patients
| Speaker: | John Aruny, New Haven, United States |
11:45 - 11:50
Audience Participation & Discussion
11:50 - 12:00
Panel Discussion
Venous Innovation Consensus
Time: 12:00 - 13:00
| Chairing: | Frans Moll, Utrecht, Netherlands |
12:00 - 12:05
Early clinical optimisation with microinfusion device and DEXTERITY study update
| Speaker: | Stephen Black, London, United Kingdom |
12:05 - 12:10
Audience Participation & Discussion
12:10 - 12:15
Preliminary results of SnakeBack technology for EVLT and presentation of new study protocol
| Speaker: | Guillaume Stalnikiewicz, Villeneuve d'Asq, France |
12:15 - 12:20
Audience Participation & Discussion
12:20 - 12:30
First-in-human percutaneous valve for venous insufficiency
| Speaker: | Ramon Varcoe, Sydney, Australia |
12:30 - 12:40
A new percutaneous valve
| Speaker: | Marc Glickman, Norfolk, United States |
12:40 - 13:00
Audience Participation & Discussion
Lunch Break
Time: 13:00 - 13:30
Peripheral Innovation Consensus
Time: 13:30 - 15:00
| Chairing: | Frans Moll, Utrecht, Netherlands |
13:30 - 13:35
First-in-Human experience with the eFemoral bioresorbable scaffold in femoro-popliteal disease
| Speaker: | Andrew Holden, Auckland, New Zealand |
13:35 - 13:40
Audience Participation & Discussion
13:40 - 13:45
New crossing tools for below-the-knee
| Speaker: | Jos van den Berg, Lugano, Switzerland |
13:45 - 13:50
Audience Participation & Discussion
13:50 - 13:55
Update on the RESOLV Study: Bioabsorbable sirolimus coated scaffold for BTK treatment
| Speaker: | Marianne Brodmann, Graz, Austria |
13:55 - 14:00
Audience Participation & Discussion
14:00 - 14:05
Case for everolimus BTK resorbable stents as the winning drug for limb salvage
| Speaker: | Brian DeRubertis |
14:05 - 14:10
Audience Participation & Discussion
14:10 - 14:15
Sirolimus coated balloons will improve standard of care for patients with hurting legs
| Speaker: | George Adams, Chapel Hill, United States |
14:15 - 14:20
Audience Participation & Discussion
14:20 - 14:25
Benefits of the MagicTouch sirolimus coated balloon catheter
| Speaker: | Edward Choke, Bukit Merah, Singapore |
14:25 - 14:30
Audience Participation & Discussion
14:30 - 14:35
Benefits of Selution SLR technology
| Speaker: | Peter Gaines, Sheffield, United Kingdom |
14:35 - 14:40
Audience Participation & Discussion
14:40 - 14:45
The next frontier: The role of micro-incisions in preparing the vessel for DCB
| Speaker: | Eric Secemsky, Boston, United States |
14:45 - 14:50
Audience Participation & Discussion
14:50 - 14:55
Novel atherectomy catheter with early clinical experience
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
14:55 - 15:00
Audience Participation & Discussion
Artificial Intelligence Deep Learning
Time: 15:00 - 15:50
| Chairing: | Robert Mitchell, Park City, Utah |
15:00 - 15:05
Robotic endovascular surgery: Current and future practice
| Speaker: | Guy Martin, London, United Kingdom |
15:05 - 15:10
Audience Participation & Discussion
15:10 - 15:15
Sentante: The future of endovascular interventions
| Speaker: | Tomas Baltrunas, Vilnius, Lithuania |
15:15 - 15:20
Audience Participation & Discussion
15:20 - 15:25
5 vessel branched EVAR using artificial intelligence technology
| Speaker: | Jan Heyligers, Tilburg, Netherlands |
15:25 - 15:30
Audience Participation & Discussion
15:30 - 15:35
The physical intelligence transformation of AI: Impact of the first global wireless network for vascular imaging and physiology
| Speaker: | Richard Linder, Sandy, United States |
15:35 - 15:40
Audience Participation & Discussion
15:40 - 15:50
Panel Discussion
Tea Break
Time: 15:50 - 16:10
Dragon’s Den
Time: 16:10 - 18:00
| Chairing: | Stephen Greenhalgh, London, United Kingdom |
| Panel: | Robert Mitchell, Park City, United States |
| Frans Moll, Utrecht, Netherlands | |
| Kieran Murphy, Toronto, Canada | |
| Chas Taylor, Sussex, United Kingdom | |
| George Adams, Chapel Hill, United States | |
| Jeffrey Jump, Nyon, Switzerland | |
| Patrick Kelly, Sioux Falls, United States | |
| Tom Carrell, Barrington, United Kingdom | |
| Peter Hinchliffe, New York, United States |
16:10 - 16:14
Introduction to Dragon’s Den
16:14 - 16:18
The Future of Bypass Surgery
| Speaker: | Marieke Hoogewerf, Utrecht, Netherlands |
16:18 - 16:22
Questions from the Dragons
16:22 - 16:26
The future: A simple, high-performance, drug-free device coating
| Speaker: | Tony Simula, Adelaide, Australia |
16:26 - 16:30
Questions from the Dragons
16:30 - 16:34
Medical foods and improved patient outcomes
| Speaker: | Kieran Murphy, Toronto, Canada |
16:34 - 16:38
Questions from the Dragons
16:38 - 16:42
Reduction of embolism during complex endovascular arch aneurysm repair
| Speaker: | Tilo Koelbel, Hamburg, Germany |
16:42 - 16:46
Questions from the Dragons
16:46 - 16:50
FIH Allay Aortic stent for type B aortic dissection
| Speaker: | Diane Lejeune, Gembloux, Belgium |
16:50 - 16:54
Questions from the Dragons
16:54 - 16:58
Prophylactic sac management system
| Speaker: | William Colone, San Clemente, United States |
16:58 - 17:02
Questions from the Dragons
17:02 - 17:06
Use of an extracorporeal blood pump as a bridge to surgical intervention for acute use in limb ischemia
| Speaker: | Jonathan Morrison, Jacksonville, United States |
17:06 - 17:10
Questions from the Dragons
17:10 - 17:14
Non-invasive, distant, and lifelong monitoring of AVF
| Speaker: | Ali Kordzadeh, Chelmsford, United Kingdom |
17:14 - 17:18
Questions from the Dragons
17:18 - 17:22
ECG anytime anywhere in 60 seconds
| Speaker: | Pieter Doevendans |
17:22 - 17:26
Questions from the Dragons
17:26 - 17:30
Advancing vascular medical device testing and clinical applications using tissue engineering
| Speaker: | Samand Pashneh-Tala, Hayward, United States |
17:30 - 17:34
Questions from the Dragons
17:34 - 17:38
Nano particles pulled through clot by a magnetic field to aid thrombolysis
| Speaker: | David Deaton, New York, United States |
17:38 - 17:42
Questions from the Dragons
17:42 - 17:46
Reverse flow filter pump for aspiration of embolic debris
| Speaker: | Michael Wholey, San Antonio, United States |
17:46 - 17:50
Questions from the Dragons
17:50 - 18:00
Voting by the Dragons and announcement of the winner. Photograph with Dragons' Den winner of £1000 CX Innovation prize.